What to Expect from MarineMax's Earnings
Benzinga Insights 9 months ago
Earnings
MarineMax (NYSE:HZO) is set to give its latest quarterly earnings report on Thursday, 2026-01-29. Here's what investors need to know before the announcement.
Analysts estimate that MarineMax will report an earnings per share (EPS) of $-0.10.
MarineMax bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Performance in Previous Earnings
Last quarter the company beat EPS by $0.09, which was followed by a 3.01% increase in the share price the next day.
Here's a look at MarineMax's past performance and the resulting price change:
| Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | 1.17 | 0.19 | -0.22 |
| EPS Actual | -0.04 | 0.49 | 0.23 | 0.17 |
| Price Change % | 3.00 | 1.00 | 1.00 | -5.00 |
Stock Performance
Shares of MarineMax were trading at $27.56 as of January 27. Over the last 52-week period, shares are down 11.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Views on MarineMax
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on MarineMax.
The consensus rating for MarineMax is Buy, derived from 1 analyst ratings. An average one-year price target of $29.0 implies a potential 5.22% upside.
Comparing Ratings with Peers
The following analysis focuses on the analyst ratings and average 1-year price targets of Build-A-Bear Workshop, Petco Health and Wellness and Envela, three prominent industry players, providing insights into their relative performance expectations and market positioning.
- Analysts currently favor an Buy trajectory for Build-A-Bear Workshop, with an average 1-year price target of $69.29, suggesting a potential 151.42% upside.
- Analysts currently favor an Neutral trajectory for Petco Health and Wellness, with an average 1-year price target of $4.0, suggesting a potential 85.49% downside.
- Analysts currently favor an Buy trajectory for Envela, with an average 1-year price target of $14.0, suggesting a potential 49.2% downside.
Peers Comparative Analysis Summary
In the peer analysis summary, key metrics for Build-A-Bear Workshop, Petco Health and Wellness and Envela are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| MarineMax | Buy | -1.95% | $191.44M | -0.09% |
| Build-A-Bear Workshop | Buy | 2.72% | $65.82M | 5.31% |
| Petco Health and Wellness | Neutral | -3.11% | $569.01M | 0.81% |
| Envela | Buy | 22.37% | $13.07M | 5.65% |
Key Takeaway:
MarineMax ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
About MarineMax
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.
A Deep Dive into MarineMax's Financials
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: MarineMax's revenue growth over 3 months faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately -1.95%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: MarineMax's net margin is impressive, surpassing industry averages. With a net margin of -0.15%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): MarineMax's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.09%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.03%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 1.33, MarineMax faces challenges in effectively managing its debt levels, indicating potential financial strain.
To track all earnings releases for MarineMax visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.